ENTtoday
  • Home
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Multimedia
    • Video
    • Audio
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
    • eNewsletters
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

New Paradigms Emerging in Diagnosis, Management of Thyroid Cancer

by John Austin • December 1, 2006

  • Tweet
  • Email
Print-Friendly Version

The incidence of thyroid cancer is increasing rapidly in the United States and the past few years have seen dramatic shifts in the management of papillary and follicular thyroid cancer. Knowledge of these emerging trends is important to optimize patient care and endocrine referral patterns for head and neck surgeons performing thyroid surgery.

You might also like:

  • Management Issues in Recurrent and Metastatic Thyroid Cancer
  • New Evidence-Based Guidelines on Thyroid Cancer
  • Shifting Paradigms in Thyroid Cancer Follow-Up
  • Updated Thyroid Nodule Guidelines Give Recommendations on Diagnosis, Treatment
Explore this issue:
December 2006

We really need to look at where we stand in what I think is going to turn out to be a clinical epidemic, said Shereen Ezzat, MD, Professor of Endocrinology and Metabolism at the University of Toronto and a senior scientist in the Division of Applied Molecular Oncology at the Ontario Cancer Institute.

Dr. Ezzat was one of a distinguished roster of endocrine, imaging, and surgical experts on hand to update attendees on the most current trends and evolving paradigms in the diagnosis and management of thyroid cancer at the recent American Academy of Otolaryngology-Head and Neck Surgery annual meeting in Toronto.

It’s anticipated that, in the next five years, diagnoses of thyroid cancer are going to double, he said We have to look at the scope of the problem and where the deficiencies are-and, unfortunately, there are lots of them.

At the Molecular Level

Dr. Ezzat discussed the evolution of molecular diagnostic techniques and how those techniques are going to affect physicians’ understanding of the disease and, ultimately, how that will be translated into the therapeutic arena.

A thyroid nodule can be benign, it can be cystic, inflammatory, or it could represent an area of compensatory regeneration or hyperplasia, he said. But what we’re really most interested in is the area of neoplasia, where potentially clinical significance would have the greatest meaning.

Before subjecting a patient to diagnostic testing, as well as determining which tests to perform, Dr. Ezzat said physicians should consider the following statistics from a recent study: In nonirradiated patients, the risk of malignancy is 5%, while in irradiated patients, the risk increases to 30% to 40%. If there is some degree of autonomous function, the risk is less than 5%.

That’s what I already know, and if any test does not really add to this, then it’s kind of useless, he said. Part of the problem is that we like to rely on morphology. Morphology requires at least six criteria based on aspirate findings to make the diagnosis of papillary cancer. And only when all these criteria are met is the pathologist able to tell you that you’ve got papillary cancer. That’s the limitation, so I don’t think we should be too hard on the pathologist.

Pages: 1 2 3 4 5 6 7 Single Page

Filed Under: Departments, Head and Neck, Practice Focus Tagged With: cancer, diagnosis, Imaging, outcomes, radiation, risk, surgery, thyroid cancer, treatmentIssue: December 2006

You might also like:

  • Management Issues in Recurrent and Metastatic Thyroid Cancer
  • New Evidence-Based Guidelines on Thyroid Cancer
  • Shifting Paradigms in Thyroid Cancer Follow-Up
  • Updated Thyroid Nodule Guidelines Give Recommendations on Diagnosis, Treatment

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • How Writing Helps a Medical Resident Better Care for Patients
  • How Physicians Can Build a Network to Boost Their Career
  • How To Survive the First Year of Medical Residency
  • ACGME Revises Cap on Resident Work Hours
  • Ethical Implications of Burnout in Otolaryngology Residents
  • Popular this Week
  • Most Popular
  • Most Recent
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Counseling Patients on Safe Nasal Irrigation
    • Is There a Crisis in the Otolaryngology Match?
    • Weaning Patients Off of PPIs
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Short-and Long-Term Data Suggest Efficacy of Turbinate Ablation
    • Counseling Patients on Safe Nasal Irrigation
    • Artificial Intelligence and Machine Learning in Otolaryngology
    • Letter from the Editor: Peer Reviewing Sensational Headlines
    • Is Topical Epinephrine Safe for Hemostasis in Endoscopic Sinus Surgery?
    • Is it Safe to Kiss in Era of HPV Head and Neck Cancer ‘Epidemic’?

Polls

Is artificial intelligence an advantage for medicine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy

Visit: The Triological Society • The Laryngoscope • Triological Meeting Posters

Wiley
© 2019 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.